Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,578 | -1,922 | -1,128 | -584 | -2,193 |
| Depreciation Amortization | 10 | 7 | 4 | 2 | 3 |
| Accounts receivable | 0 | 7 | -101 | 63 | N/A |
| Accounts payable and accrued liabilities | 396 | 126 | -30 | -185 | N/A |
| Other Working Capital | 238 | -28 | -65 | -171 | 312 |
| Other Operating Activity | -305 | -122 | 142 | 122 | 9 |
| Operating Cash Flow | $-3,240 | $-1,932 | $-1,177 | $-753 | $-1,869 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21 | -6 | -5 | -5 | -14 |
| Investing Cash Flow | $-21 | $-6 | $-5 | $-5 | $-14 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 738 | 708 | 285 | 285 | N/A |
| Other Financing Activity | 9,749 | 10,219 | 1,098 | 1,108 | 1,751 |
| Financing Cash Flow | $10,487 | $10,927 | $1,382 | $1,393 | $1,751 |
| Exchange Rate Effect | -35 | -24 | 0 | -4 | 34 |
| Beginning Cash Position | 314 | 314 | 314 | 314 | 411 |
| End Cash Position | 7,504 | 9,279 | 514 | 945 | 314 |
| Net Cash Flow | $7,191 | $8,965 | $200 | $631 | $-97 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,240 | -1,932 | -1,177 | -753 | -1,869 |
| Capital Expenditure | -21 | -6 | -5 | -5 | N/A |
| Free Cash Flow | -3,261 | -1,938 | -1,182 | -758 | -1,869 |